Ipek Erdogan-Trinkaus - Dec 2, 2024 Form 3 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Commercial Officer
Signature
/s/ Ipek Erdoga-Trinkaus
Stock symbol
ETON
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
3
Date filed
12/9/2024, 05:11 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETON Employee Stock Option (Right to Buy) Dec 2, 2024 Common Stock 75K $12.46 Direct F1
holding ETON Restricted Stock Units Dec 2, 2024 Common Stock 8.03K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) The Employee Stock Options and Restricted Stock Units will vest in four equal installments on December 2, 2025, 2026, 2027, and 2028.